Debora Barton

Company: TScan Therapeutics

Job title: Chief Medical Officer

Seminars:

Multiplexed TCRs Addressing HLA Loss in Solid Tumors 5:00 pm

Developing multiplexed TCRs with the ability to adapt and recognize tumor-specific antigens, compensating for potential HLA loss in the dynamic landscape of solid tumors Discussing engineering strategies enabling multiplexed TCRs to discern and target cancer cells even in scenarios of HLA downregulation, optimizing therapeutic efficacy Unveiling the potential of multiplexed TCRs to enhance therapeutic resilience…Read more

day: DAY ONE TRACK 4 B